Open AccessIntravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
Author(s) -
Mehmet Demir,
Oba,
Gulkilik,
Odabasi,
Ozdal
Publication year - 2011
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s19279
Subject(s) - medicine , ophthalmology , branch retinal vein occlusion , macular edema , bevacizumab , retinal vein , retinal , occlusion , surgery , chemotherapy
To present the functional and anatomic changes after intravitreal bevacizumab in eyes with macular edema (ME) due to branch retinal vein occlusion (BRVO).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom